Accessibility Menu

Immunovia Ab (publ)

(OTC) IMMVF

Current Price$0.02
Market Cap$13.45M
Since IPO (2019)-100%
5 Year-100%
1 Year-60%
1 Month+0%

Immunovia Ab (publ) Financials at a Glance

Market Cap

$13.45M

Revenue (TTM)

SEK 916.83K

Net Income (TTM)

-SEK 106.25M

EPS (TTM)

-$0.03

P/E Ratio

-0.78

Dividend

$0.00

Beta (Volatility)

1.09 (Average)

Price

$0.02

Volume

600,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.15

Estimated Earnings Date

Aug 6, 2026

IMMVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immunovia Ab (publ)

Industry

Healthcare Equipment and Supplies

Employees

17

CEO

Jeff Borcherding, MBA

Headquarters

Lund, 223 63, SE

IMMVF Financials

Key Financial Metrics (TTM)

Gross Margin

-37%

Operating Margin

-86%

Net Income Margin

-116%

Return on Equity

-288%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-1.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.45M

Shares Outstanding

672.67M

Volume

600.00K

Avg. Volume

9.38K

Financials (TTM)

Gross Profit

-SEK 79.30M

Operating Income

-SEK 79.30M

EBITDA

-SEK 76.99M

Operating Cash Flow

-SEK 78.20M

Capital Expenditure

SEK 0.00

Free Cash Flow

-SEK 78.20M

Cash & ST Invst.

SEK 77.26M

Total Debt

SEK 854.85K

Immunovia Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 372.73K

+168.1%

Gross Profit

-SEK 17.61M

-12767.7%

Gross Margin

-47.24%

N/A

Market Cap

$13.45M

N/A

Market Cap/Employee

$1.49M

N/A

Employees

9

N/A

Net Income

-SEK 18.37M

+68.2%

EBITDA

-SEK 17.59M

+2.3%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 55.90M

+48.4%

Total Debt

SEK 477.37K

+334.0%

Accounts Receivable

SEK 2.25M

N/A

Inventory

SEK 169.42K

N/A

Long Term Debt

SEK 0.00

N/A

Short Term Debt

SEK 477.37K

+334.0%

Return on Assets

-1.62%

N/A

Return on Invested Capital

-1.70%

N/A

Free Cash Flow

-SEK 20.82M

+14.5%

Operating Cash Flow

-SEK 20.82M

+14.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASAPFAurora Spine Corporation
$0.16-7.02%
UEECUnited Health Products, Inc.
$0.06-6.34%
ZHCLFZenith Capital Corp.
$0.02-60.00%
PPCBPropanc Biopharma, Inc.
$2.27-6.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About IMMVF

What is the current price of Immunovia Ab (publ)?

Immunovia Ab (publ) is trading at $0.02 per share.

What is the 52-week range for Immunovia Ab (publ)?

Over the past 52 weeks, Immunovia Ab (publ) has traded between $0.02 and $0.15.

How much debt does Immunovia Ab (publ) have?

As of the most recent reporting period, Immunovia Ab (publ) reported total debt of SEK 50.28K.

How much cash does Immunovia Ab (publ) have on hand?

Immunovia Ab (publ) reported SEK 5.89M in cash and cash equivalents in its most recent financial results.

What is Immunovia Ab (publ)’s dividend yield?

Immunovia Ab (publ) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.